JP2016044170A5 - - Google Patents

Download PDF

Info

Publication number
JP2016044170A5
JP2016044170A5 JP2014172328A JP2014172328A JP2016044170A5 JP 2016044170 A5 JP2016044170 A5 JP 2016044170A5 JP 2014172328 A JP2014172328 A JP 2014172328A JP 2014172328 A JP2014172328 A JP 2014172328A JP 2016044170 A5 JP2016044170 A5 JP 2016044170A5
Authority
JP
Japan
Prior art keywords
stearic acid
excipient
olmesartan medoxomil
granulated product
particle size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014172328A
Other languages
English (en)
Japanese (ja)
Other versions
JP6653116B2 (ja
JP2016044170A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014172328A priority Critical patent/JP6653116B2/ja
Priority claimed from JP2014172328A external-priority patent/JP6653116B2/ja
Publication of JP2016044170A publication Critical patent/JP2016044170A/ja
Publication of JP2016044170A5 publication Critical patent/JP2016044170A5/ja
Application granted granted Critical
Publication of JP6653116B2 publication Critical patent/JP6653116B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014172328A 2014-08-27 2014-08-27 オルメサルタンのプロドラッグ製剤 Active JP6653116B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014172328A JP6653116B2 (ja) 2014-08-27 2014-08-27 オルメサルタンのプロドラッグ製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014172328A JP6653116B2 (ja) 2014-08-27 2014-08-27 オルメサルタンのプロドラッグ製剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019089234A Division JP6765473B2 (ja) 2019-05-09 2019-05-09 オルメサルタンのプロドラッグ製剤

Publications (3)

Publication Number Publication Date
JP2016044170A JP2016044170A (ja) 2016-04-04
JP2016044170A5 true JP2016044170A5 (de) 2017-08-24
JP6653116B2 JP6653116B2 (ja) 2020-02-26

Family

ID=55635052

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014172328A Active JP6653116B2 (ja) 2014-08-27 2014-08-27 オルメサルタンのプロドラッグ製剤

Country Status (1)

Country Link
JP (1) JP6653116B2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2760261T3 (es) 2014-02-13 2020-05-13 Incyte Corp Ciclopropilaminas como inhibidores de LSD1
HUE045725T2 (hu) 2014-02-13 2020-01-28 Incyte Corp Ciklopropilaminok mint LSD1 inhibitorok
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
MX2017012699A (es) 2015-04-03 2018-02-09 Incyte Corp Compuestos heterociclicos como inhibidores de demetilasa 1 especifica de lisina (lsd1).
KR20180051523A (ko) 2015-08-12 2018-05-16 인사이트 코포레이션 Lsd1 저해제의 염
WO2020047198A1 (en) 2018-08-31 2020-03-05 Incyte Corporation Salts of an lsd1 inhibitor and processes for preparing the same
CA3164198A1 (en) * 2020-01-16 2021-07-22 Eisai R&D Management Co., Ltd. Drug substance of lemborexant and medicinal composition comprising same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5000491B2 (ja) * 2005-05-20 2012-08-15 第一三共株式会社 フィルムコーティング製剤
US20070105923A1 (en) * 2005-09-14 2007-05-10 Glenmark Pharmaceuticals Limited Substantially pure olmesartan medoxomil and processes for its preparation
ATE526963T1 (de) * 2006-05-04 2011-10-15 Lek Pharmaceuticals Pharmazeutische zusammensetzung mit olmesartan- medoxomil
KR20090122455A (ko) * 2007-03-23 2009-11-30 다이이찌 산쿄 가부시키가이샤 올메사탄 메독소밀의 분쇄 결정
WO2010018777A1 (ja) * 2008-08-11 2010-02-18 第一三共株式会社 におい抑制方法
ES2404811T3 (es) * 2008-12-30 2013-05-29 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Formulaciones farmacéuticas de olmesartán
HUP0900384A2 (en) * 2009-06-19 2011-01-28 Nangenex Nanotechnologiai Zartkoerueen Muekoedoe Reszvenytarsasag Nanoparticulate olmesartan medoxomil compositions
WO2011045760A2 (en) * 2009-10-13 2011-04-21 Ranbaxy Laboratories Limited Micronized olmesartan medoxomil compositions
JP5680898B2 (ja) * 2010-08-10 2015-03-04 京都薬品工業株式会社 苦味を抑制した速崩壊錠
WO2014080365A1 (en) * 2012-11-23 2014-05-30 Ranbaxy Laboratories Limited Method of reducing an unpleasant odor of a pharmaceutical composition

Similar Documents

Publication Publication Date Title
JP2016044170A5 (de)
JP2015078230A5 (de)
JP2016065086A5 (de)
MX2013014788A (es) Liberacion modificada de 4-metil-3-[[4-(3-piridinl)-2-pirimidinil] -amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluoro-metil)-fenil ]-benzamida solubilizada utilizando acidos organicos.
RU2020119391A (ru) Получение тетрациклического соединения, содержащегося в высокой дозе
RU2011141496A (ru) Таблетки и гранулированные порошки, содержащие 6-фтор-3-гидрокси-2-пиразинкарбоксамид
EP4349406A3 (de) Kristalline feste formen von 6-carboxy-2-(3,5-dichlorphenyl)-benzoxazol zur verwendung als arzneimittel
FI2914248T4 (fi) Farmaseuttisia koostumuksia cftr-välitteisten tautien hoitamiseksi
MY148878A (en) Stabilized amorphous forms of imatinib mesylate
MX2019005302A (es) Pastilla de liberacion controlada a base de alcohol de polivinilo y su manufactura.
AR100977A1 (es) Formulación compuesta para la administración oral que comprende ezetimiba y rosuvastatina, y un proceso para su preparación
MX2008011579A (es) Forma galenica divisible que permite una liberacion modificada del principio activo.
JP2018513863A5 (de)
MX2017016163A (es) Comprimidos de liberación inmediata que contienen un fármaco y procesos para formar los comprimidos.
JP2014024874A5 (de)
WO2012053785A3 (ko) 타크롤리무스를 유효성분으로 함유하는 서방형 펠렛
MX2016010169A (es) Formulacion de tableta para compuestos activos de peptido relacionado con el gen de calcitonina.
RU2019138248A (ru) Фармацевтическая композиция для перорального введения, содержащая энзалутамид
JP2017515879A5 (de)
MD20150053A2 (ro) Produs de comicronizare cu conţinut de acetat de ulipristal
IN2014DE03239A (de)
JP2015129175A5 (de)
JP2014218523A5 (de)
JP2015129124A5 (de)
JP2014062064A5 (de)